Matthew W. Foehr - May 28, 2021 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Role: President and COO
Signature: By: Charles S. Berkman For: Matthew W. Foehr
Stock symbol: LGND
Transactions as of: May 28, 2021
Transactions value $: $98,736
Form type: 4
Date filed: 6/1/2021, 04:59 PM
Next filing: Jun 10, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LGND	Common Stock	Gift	$0	-2.5K	-1.51%	$0.00	163K	May 28, 2021	Direct	F1
transaction	LGND	Common Stock	Options Exercise	$98.7K	+1.76K	+1.08%	$56.26	164K	May 28, 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LGND	Employee Stock Option (right to buy)	Options Exercise	$0	-1.76K	-4.17%	$0.00	40.4K	May 28, 2021	Common Stock	1.76K	$56.26	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Charitable gift to a third party.
F2	Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant was 02/10/15.